Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Mounjaro, manufactured by Lilly, may have emerged as the newest ... on other background drugs being administered as a standard of care. A trial can still be conducted without taking a patient ...

Eli Lilly is just weeks away from launching Mounjaro in the UK ... welcomed by patient organisation Diabetes UK, whose head of care, Douglas Twenefour, said: “Supporting people with type ...

Novo Nordisk and Eli Lilly have used submissions to the federal government’s budget process to argue reducing obesity will be ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

We recently published a list of the 12 Best Long-Term Growth Stocks to Buy Now. In this article, we are going to take a look ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

GLP-1 drugs like Ozempic and Wegovy revolutionized weight loss, but their high cost keeps them out of reach for most ...

Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.

Telehealth stock Hims & Hers (HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper ...